Description
Eltrombopag was initially approved by the U.S. Food and Drug Administration (FDA) on 20 November 2008, for the treatment of thrombocytopenia in people with chronic immune (idiopathic) thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulin therapy, or splenectomy.
On 24 August 2015, the FDA approved eltrombopag (Promacta for oral suspension) for the treatment of thrombocytopenia in children one year and older with idiopathic thrombocytopenia who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
List Of Generic Brands For Elatrombopag Olamine Tablets In India
If you are looking generic brands for Elatrombopag Olamine Tablets in India. Please contact us at +91 9953466646 or drop us an email at sales@aarkpharma.com. Our representatives will be happy to assist you and answer any questions you may have Elatrombopag Olamine Tablets Price is available at Aark Pharmaceuticals.